2023 Cardiovascular Nursing Symposium – Pharmacology Sessions
Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and registered nurses in cardiology and primary care settings. PCNA’s 2023 pharmacology CE…
Read MoreThyroid Disorders and their Relationship to Cardiovascular Disease
In this comprehensive course, delve into the intricate world of thyroid disorders and their intricate connection to cardiovascular health. By the end of this course, participants will possess a deep…
Read MoreAntiplatelet Therapy in CVD Prevention
Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the…
Read MoreInherited Genetic Lipid Disorders: An Overview
In this course, you’ll hear from both a clinician and a patient living with familial hypercholesterolemia on the effects of dyslipidemia. Review dyslipidemia, its pathophysiology, effects, and pharmacological management with…
Read MorePreventing the Progression of Chronic Kidney Diease: Pharmacologic Management of Patients with Complex Co-Morbidities
Hear from Carol Headley DNS, ACNP on the complex management of patients with chronic kidney disease. Learn about how the renal and cardiovascular systems interact and what those implications are…
Read MoreGLP-1 Receptor Agonists and Cardiovascular Outcomes
In this free pharmacology continuing education course, Eryn Bryant, RN, MS, ANP discusses the use of GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice. This CE course describes the cardiovascular…
Read MoreSGLT2 Inhibitors and Cardiovascular Outcomes
Atherosclerotic Cardiovascular Disease, Heart Failure, and SGLT2 Inhibitors This SGLT2 inhibitor continuing education course provides timely insights into implementing evidence-based treatment strategies related to atherosclerotic cardiovascular disease, heart failure, and…
Read More